TSHA-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TSHA-101, covering 2023-05-09 to 2023-05-09. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis [Phase 1, Phase 2]